David Liu launches Beam Therapeutics to treat genetic diseases with CRISPR base editing
News: Base Editing Provides Potential Cure For Sickle Cell Disease Says Scientists - CRISPR Medicine
DAVID LIU, MD, MPH, MS - INTEGRATIVE PRECISION ONCOLOGY - HOME
David Liu – Brain Language and Bilingualism Lab
David Liu - The Boston Globe
David R. Liu | Department of Chemistry and Chemical Biology
New CRISPR Gene-editing Approach Under Development at Broad Institute Could Lead to Improved Clinical Laboratory Diagnostics for Genetic Diseases - Dark Daily
Lighting Up the Laboratory | News | The Harvard Crimson
Nature's 10
David R. Liu | Broad Institute
Negative plus – Harvard Gazette
Advances in DNA Editing Are Changing the Field | NIH Record
Broad researcher David Liu describes the power of single-letter base editing. - YouTube
Targeting a Genetic Accident to Treat Disease | The Scientist Magazine®
David R. Liu | Broad Institute
David R. Liu, PhD | HHMI
David Liu - Creative Destruction Lab
A New PACE for Laboratory Evolution | HHMI
David Liu Lab
David Liu - STAT
Beam Therapeutics receives Harvard license to use base editing technology to make precision genetic medicines – Harvard Gazette
DAVID LIU, MD, MPH, MS - INTEGRATIVE PRECISION ONCOLOGY - HOME
David Liu, MD, MPH, MS - Dana-Farber Cancer Institute | Boston, MA
New CRISPR technology could revolutionise gene therapy, offering new hope to people with genetic diseases
liugroup (@liugroup) / Twitter
